Medications/Drugs News Headlines

PARIS (Reuters) - For pharmaceutical companies, Africa is changing. Not only is the continent's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is luring Big Pharma, as new opportunities open up for treating chronic diseases afflicting the middle classes, rather than just fire-fighting …

NEW YORK (Reuters) - Eli Lilly and Co's chief executive said his company had no intention of following Pfizer's lead by spinning off or selling the company's lucrative Elanco animal health unit. "We're comfortable with that business and we're going to keep it," Lilly CEO John Lechleiter said definitively on Monday during …

We are a nation of advocates. Of changemakers. Of visionaries. We have achieved incredible medical advancements, such as developing childhood vaccines for adult cancers. When we decide as a nation that something should happen, it does. 

CHICAGO (AP) — Shootings and other traumatic events involving children are not rare events, but there's a startling lack of scientific evidence on the best ways to help young survivors and witnesses heal, a government-funded analysis found.

COPENHAGEN (Reuters) - U.S. regulators refused to approve Novo Nordisk's new long-acting insulin Tresiba until it conducts extra tests for potential heart risks, dealing a major blow to a key product for the Danish drugmaker. Shares in Novo, the world's leading insulin maker and the most valuable company in the Nordic region, …

COPENHAGEN (Reuters) - U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks. Novo, the world's biggest insulin maker, said the U.S. Food and Drug Administration (FDA) had requested …

WASHINGTON (Reuters) - Exports of U.S. pharmaceuticals to Iran were cut in half last year, according to data released on Friday, while overall U.S. exports to the Islamic republic rose about nine percent because of grain sales. The official U.S. government statistics appear to support the claims of sanctions lawyers and …

(Reuters) - U.S. regulators have approved a new drug from Celgene Corp for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. The U.S. Food and Drug Administration said on Friday it approved the drug, Pomalyst, also known as pomalidomide, for the most difficult-to-treat …

NEW YORK (Reuters Health) - Seniors taking psychiatric drugs may be at extra high risk for falling, new Dutch research suggests. Of about 400 elderly people in the study, those who took medications including antidepressants and antipsychotics were twice as likely to report having fallen three or more times in the previous …

(Reuters) - Oncolytics Biotech Inc said a mid-stage trial of its experimental lung cancer drug showed that 95 percent of the patients experienced a reduction in the size of their tumors, sending its stock up as much as 38 percent. Shares of the company, with a market value of about C$279 million ($273 million) as of Thursday …

CHICAGO (Reuters) - Proposed U.S. guidelines may make it easier for drug companies to test Alzheimer's treatments in people at an earlier stage, when scientists think they may have the best shot at working. The draft guidance document, issued on Thursday by the U.S. Food and Drug Administration, reflects changes in scientists' …

LONDON (Reuters) - Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny. The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed …

NEW YORK (Reuters) - Amgen Inc said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's biggest sellers, including the main rivals for its own blockbuster rheumatoid arthritis drug Enbrel. The company on Thursday …

WASHINGTON (Reuters) - The patent on Merck & Co's cholesterol fighters Zetia and Vytorin, two of the drugmaker's biggest products, is valid, a U.S. appeals court ruled on Thursday. Vytorin combines Zocor, a member of the statin family developed by Merck, with a newer Merck cholesterol treatment called Zetia. Sales of Vytorin …

(Reuters) - Vivus Inc, vying to create the world's first billion-dollar weight-loss pill, is taking a cautious approach to marketing in an attempt to overcome the skepticism, safety concerns and lawsuits that have dogged the diet drug industry. The company has lost nearly half of its market value since lackluster sales …

If you have some types of cancer and your treatment includes chemotherapy, there’s a good chance you’ll be prescribed the drug Doxil. If your doctor can get her hands on any, that is. Doxil is one of many crucial drugs that’s in seriously short supply.

Unhealthy Glow: Fluorescent Tadpoles Expose Chemical Contamination

Drug-Free Technique Might Help Some Patients Who Struggle With Depression

BOSTON (Reuters) - Biogen Idec Inc's agreement to buy Elan Corp Plc's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious. Analysts have speculated for several years that Biogen could acquire …

WASHINGTON (AP) — The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.

CHICAGO (Reuters) - The number of U.S. residents aged 65 and older living with Alzheimer's disease is expected to nearly triple to 13.8 million by 2050 as aging baby boomers swell the ranks of those living with the brain-wasting disease, U.S. researchers said on Wednesday. The new estimates, published in the journal Neurology, …

Suitulaga Hunkin Lost Weight for a Heart Transplant

LOS ANGELES (Reuters) - Oscar-winning filmmaker Steven Soderbergh delves into the world of prescription drugs in his new film "Side Effects," a psychological thriller that opens on Friday. Rooney Mara and Channing Tatum play a couple whose lives unravel when she begins taking a new anti-anxiety medication prescribed by …